Cadila Healthcare informs about press release

29 Dec 2017 Evaluate

Cadila Healthcare has informed about press release titled ‘Zydus receives final approval from the USFDA for Clomipramine Hydrochloride Capsules USP.’

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

912.00 -2.65 (-0.29%)
01-Jan-2026 13:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.00
Dr. Reddys Lab 1250.40
Cipla 1501.10
Zydus Lifesciences 912.00
Lupin 2100.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×